ArticleInternal and emergency medicine2025
Why internists should care about Helicobacter pylori: recapitulating gastric cancer prevention.
Article in Internal and emergency medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Updating the Prevalence ofJournal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Infection with Helicobacter pylori (H. pylori) is a leading but also modifiable cause of gastric cancer. However, evidence indicates that the goal of a primary prevention of gastric cancer is still far from being achieved. Main obstacles derive from inadequate screening and management of H. pylori infection but also from other external risk factors, responsible for about a quarter of future cases of gastric cancer. The need for population-based H. pylori screen-and-treat programs remains not fully addressed, mainly due to concerns about cost, to underpowered screening efficacy of policies only targeting symptomatic people, to the lack of screen-and-treat approach performed early. Further concerns derive from persisting gaps between guideline-recommended H. pylori management and real-world patterns, leading to inappropriate therapies and increased antimicrobial resistance. A critical role is also played by unhealthy lifestyle and by environmental factors other than H. pylori. In fact, critical external factors increasing the risk of gastric cancer originate from the contamination of environmental matrices and of the food chain with toxic chemicals of anthropogenic origin. An effective strategy for the primary prevention of gastric cancer should therefore consider a full implementation of population-based screen-and-treat programs, but also educational strategies oriented to correct unhealthy habits, and rules and policies oriented to decrease the involuntary exposure to toxic chemicals. In the absence of this comprehensive approach and urgent and efficient prevention policies, local health systems should be prepared to manage the high cost deriving from the growing burden of a preventable (but not prevented) disease, as is gastric cancer. Maximal efforts should also be oriented to ensure a correct application of the available guidelines for the management of H. pylori infection. This goal should lead to an accurate selection of the best treatment regimen, but also to antibiotic stewardship, and to constant monitoring of outcomes and epidemiologic data, to improve quality and equity of care. Internist as well urge to master such topics which involve present and future key public health issues.
Indexed as
Identifiers
40886213What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.